New diabetes combo drug put to the test in healthy volunteers
NCT ID NCT07538466
First seen Apr 21, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This early-stage study will test a new combination diabetes medicine (AD-123) in 50 healthy adults. Researchers want to see how the body processes the drug when given as a single pill versus taking two separate pills. The study is not yet recruiting and focuses on safety and drug levels in the blood, not on treating diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H Plus Yangji Hospita
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.